Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Hanmi Science Co Ltd patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| WO2022164222A3 | Application | PHARMACEUTICAL COMPOSITION COMPRISING GIP DERIVATIVE OR LONG-ACTING CONJUGATE THEREOF FOR PREVENTING OR TREATING PULMONARY DISEASE | A61K38/16; A61K38/22; A61K47/68; A61P11/00; A61P31/14; C07K14/72; C07K19/00 | September 15, 2022 |
| WO2022192202A1 | Application | BELVARAFENIB FOR USE IN TREATMENT OF BRAIN CANCERS | A61K31/4523; A61K31/519; A61P35/04 | September 15, 2022 |
| EP3907225A4 | Search Report | IMIDAZOPYRIDINDERIVATVERBINDUNGEN UND IHRE VERWENDUNG | A61K31/4439; A61K45/06; A61P35/00; C07D471/04; C07D519/00 | September 14, 2022 |
| AU2020423596A1 | Application | Therapeutic use of long-acting conjugate of triple agonist having activity with respect to all of glucagon and GLP-1 and GIP receptors against lung disease | A61K38/16; A61K38/17; A61K38/1709; A61K38/1796; A61K38/22; A61K38/2278; A61K38/26; A61K47/60; A61K47/68; A61K47/6811; A61P1/16; A61P11/00; C07K14/47; C07K14/575; C07K14/605; Y02A50/30 | September 08, 2022 |
| EP3900735A4 | Search Report | PHARMAZEUTISCHE ZUSAMMENSETZUNG MIT INSULIN UND DREIFACHAGONISTEN MIT AKTIVITÄT GEGENÜBER ALLEN GLUCAGON- UND GLP-1- UND GIP-REZEPTOREN | A61K38/26; A61K38/28; A61K47/60; A61K47/68; A61K47/6811; A61P3/04; A61P3/10; C07K14/605; C07K14/62 | September 07, 2022 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer